How much does sirolimus albumin-bound nanoparticle injection (FYARRO) cost?

Sirolimus albumin-bound nanoparticle injection (FYARRO) is used to treat a certain type of epithelioid cell tumor (soft tissue tumor that can form anywhere in the body) that has spread to nearby tissue or other parts of the body or that cannot be removed with surgery. Sirolimus albumin-bound nanoparticle injection belongs to the kinase inhibitor class of drugs, which prevents the reproduction of cancer cells by blocking the activity of abnormal proteins, which may help slow down the growth of tumors.

Sirolimus Albumin-Bound Nanoparticle Injection is a suspension (liquid) that can be administered by intravenous infusion (slowly injected into a vein) over 30 minutes. Typically administered by a physician or nurse in a doctor's office or infusion center, Sirolimus Albumin-Bound Nanoparticle Injection is usually administered on Days 1 and 8 of a 21-day cycle. If a patient develops side effects (reaction to a drug) while being treated with a drug, the doctor may need to interrupt treatment, reduce the dose, or stop treatment.

The original drug of sirolimus albumin-bound nanoparticle injection is a new type of drug for treating diseases. It is not currently on the market in China and therefore is not included in medical insurance. The common dosage form of sirolimus albumin-bound nanoparticle injection original drug is injection, which has been marketed overseas. US version specifications The price of each 100mg tube may be around RMB 60,000 (the price may fluctuate due to the exchange rate), which is relatively expensive. Currently, there is no generic version of Sirolimus Albumin-Bound Nanoparticle Injection on the market. For more drug information and specific prices, please consult Yaode Medical Consultants.